Trial Profile
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Sodium thiosulfate (Primary)
- Indications Calciphylaxis
- Focus Adverse reactions; Registrational
- Acronyms OF-CALISTA
- Sponsors Hope Pharmaceuticals
- 18 Nov 2018 Status changed from recruiting to discontinued.
- 31 Oct 2017 New trial record